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Despite its critical role in response to DNA 
damage treatment, p53 is dispensable for cer-
tain stress stimuli, such as cytokine withdrawal-
induced apoptosis in lymphoid cells (1, 2). In 
contrast, the PI3K–Akt signaling pathway has 
been shown to mediate cell survival under 
these conditions (3, 4), possibly through inhi-
bition of FOXO transcription factors. However, 
the critical mediators downstream of FOXOs 
still remain unclear.
Puma was originally identifi   ed as a p53 
downstream target (5–7). Puma defi  ciency is 
known to protect cells from genotoxic stress 
that causes activation of p53. Additionally, 
cells lacking Puma are also resistant to several 
p53-independent death stimuli. For instance, 
defi  ciency  of  Puma renders myeloid pro-
genitor cells resistant to cytokine withdrawal 
(1, 2, 8, 9). Interestingly, Puma mRNA levels 
were up-regulated under these conditions. In 
addition to this, a variety of growth factors, 
for instance, insulin-like growth factor-1 and 
epidermal growth factor, can suppress Puma 
expression in serum-starved tumor cells (6). 
Notably, one of the common features shared 
by some of these stress stimuli that cause p53-
independent Puma up-regulation is that they 
could attenuate the PI3K–Akt signaling path-
way, which in turn modulates the activity of 
FOXO transcription factors.
In this report, we demonstrate that upon 
removing survival factors in lymphoid cells 
or mouse embryonic fi  broblast (MEF) cells, 
FOXO3a (one of the FOXO family members) 
can regulate Puma at the transcriptional level. 
This indicates that abnormal PI3K–Akt signal-
ing could exert its survival eff  ect through atten-
uating critical pro-apoptotic pathways involving 
BH3-only family members such as Puma.
RESULTS AND D  I  S  C  U  S  S  I  O  N 
The PI3K–Akt pathway is involved 
in cytokine withdrawal-induced apoptosis 
in lymphoid cells
Lymphoid cells subjected to stresses such as cy-
tokine withdrawal undergo apoptosis in a p53-
independent manner (unpublished data). Our 
laboratory has previously reported that T cells 
derived from Ptenfl  ox/− Lck-Cre mice are resis-
tant to apoptosis induced by IL-2 deprivation 
(10), suggesting that the mechanism mediating 
this cell death might involve the PI3K–Akt 
pathway. Pten is a critical negative regulator of 
the Akt pathway and frequently inactivated in 
human cancers (11). In this study, we con-
fi   rmed that T cell–specifi  c  deletion  of  Pten 
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(Ptenfl  ox/fl  ox Lck-Cre) leads to constitutive Akt activation (Fig. 
1 A, left) and that Pten-defi  cient T cells subjected to IL-2 
withdrawal show a signifi  cant protection from IL-2 with-
drawal-induced cell death (Fig. 1 A, right).These data sup-
port our hypothesis that apoptosis induced by at least some 
p53-independent stimuli requires the normal regulation of 
the PI3K–Akt pathway.
Activation of the survival kinase Akt leads to phosphory-
lation and inhibition of FOXO transcription factors. We 
therefore investigated whether FOXO3a is activated after re-
moving of cytokines in lymphocytes. FOXO3a phosphoryla-
tion was markedly inhibited after removing of IL-2 (Fig. 1 B), 
suggesting FOXO3a is activated upon IL-2 withdrawal in 
primary T cells. It also indicates that compromised FOXO3a 
activation might account for the resistance to cytokine with-
drawal-triggered apoptosis in Pten-defi  cient T cells.
FOXO3a directs Puma expression upon activation
As a transcriptional factor, FOXO3a has been shown to regu-
late cell death through several downstream targets, including 
p27 and Bim (3). To identify novel downstream target genes 
that can be induced by FOXO3a, we performed a microarray 
analysis. Because FOXO3a and p53 crosstalk with each other 
and they also share quite a few common downstream targets 
(12, 13), to enrich the signifi  cant hits that would be regulated 
by FOXO3a but independent of p53, we used inducible 
MEF cell lines (of the p53+/+ and p53−/− genetic back-
grounds) that expressed an HA-tagged FOXO3a-TM-ER 
(TM-ER) construct.
Figure 1.  PI3K/Akt/FOXO3a are involved in cytokine withdrawal-
induced apoptosis in activated T cells. (A) Resistance of Pten-  defi  cient 
activated T cells to apoptosis induced by IL-2 withdrawal. (left) Western 
blot showing levels of indicated proteins in untreated WT and Pten-defi  cient 
T cells. (right) Activated T cells were cultured in IL-2–free medium for 24 h 
and numbers of viable cells were determined by fl  ow cytometric analysis. 
Data shown are means ± SD from three independent experiments. 
(B) FOXO3a phosphorylation status in IL-2–deprived activated T cells 
  derived from p53−/− mice. Phosphorylated FOXO3a (Thr 32) (FOXO3a-P) 
and total FOXO3a (FOXO3a-T) were detected by Western blotting.
Figure 2.  Puma is a FOXO3a transcriptional target gene. (A) p53+/+ 
and p53−/− FOXO3a TM-ER MEFs were exposed to 4-OHT (0.5 μM) for 6 h 
and lysates were subjected to Western blotting using antibodies directed 
against the indicated proteins. (B) Induction of Puma expression by 
FOXO3a-TM-ER. Levels of Puma transcripts or Puma protein in WT TM-ER 
and p53−/− TM-ER MEFs either left untreated (−) or treated with 4-OHT 
(+) for 8 h were assessed by RT-PCR or Western blotting (top) and QRT-
PCR (bottom). HPRT and TBP, normalization control. Cell extracts from 
puma−/− MEFs were used as a negative control. QRT-PCR data are means ± 
SD from four independent experiments. (C) Identifi  cation of a con-
served FHRE site in the human and mouse Puma promoters. p53BE, p53-
binding element. (D) FOXO3a-TM activates a luciferase reporter gene 
driven by the Puma promoter. p53−/− MEFs were cotransfected with con-
structs as indicated. Luciferase assays were performed 24 h after trans-
fection. Data shown are means ± SD from fi  ve independent experiments 
conducted in triplicates each time. (E) Quantifi  cation of FOXO3a associa-
tion with the Puma promoter. QRT-PCR assays were conducted after 
chromatin IP using samples from cells that were either left untreated 
(con) or treated with 4-OHT. Numbers on the y-axis represent the levels of 
FOXO3a association with the Puma promoter region after normalizing to 
Ct values from input samples. Data shown are means ± SD from three 
independent experiments.JEM VOL. 203, July 10, 2006  1659
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We fi  rst confi  rmed that the expression levels and acti-
vities of the TM-ER transgene were comparable between 
p53+/+ and p53−/− MEFs (Fig. 2 A). We extracted RNA 
from WT TM-ER and p53−/− TM-ER MEFs that had been 
induced for 8 h with either 4-OHT or a vehicle control. 
Gene expression profi  les of these samples were analyzed us-
ing Aff  ymetrix GeneChips (Mouse Genome 430 2.0). Dif-
ferentially expressed candidate genes were obtained with the 
p-value set at 0.01 and had at least twofold induction. Con-
sistent with previous reports, p27 was signifi  cantly up-regu-
lated upon 4-OHT treatment (Table I). Interestingly, Puma 
mRNA as well as its protein levels were also induced upon 
TM-ER expression, even in p53−/− cells (Fig. 2 B, top). 
Quantifi  cation using QRT-PCR showed that the FOXO3a 
TM-ER induced Puma to the same degree in p53+/+ and 
p53−/− MEFs, taking into account the lower baseline of 
Puma expression in the p53−/− cells (Fig. 2 B, bottom). Our 
results indicate that constitutive activation of exogenous 
FOXO3a increases Puma expression, which might account 
for Puma induction under stress conditions that can activate 
endogenous FOXO3a.
We then determined whether FOXO3a acts directly on 
the murine Puma promoter. Promoter analysis identifi  ed 
a potential consensus FOXO-responsive element (FHRE) 
in intron 1 that is conserved between human and mouse (Fig. 
2 C). To assess the ability of FOXO3a to regulate Puma tran-
scription, we cotransfected p53−/− MEFs with FOXO3a-
TM or FOXO3a-TM∆DB together with a reporter gene in 
which the Puma promoter drives the expression of a lucifer-
ase gene (14). We found that constitutively active FOXO3a 
effi   ciently induced Puma promoter-driven luciferase activity, 
whereas FOXO3a-TM∆DB failed to induce any reporter ac-
tivity (Fig. 2 D). Replacement of the core consensus sequence 
AAC of the FHRE with GGG abolished FOXO3a-TM–
  induced luciferase activity (Fig. 2 D), indicating that this site 
is a functional FHRE. To test if FOXO3a could interact with 
the endogenous Puma promoter, a ChIP assay was performed 
in which the FOXO3a–TM–DNA complex was purifi  ed 
from p53+/+ or p53−/− FOXO3a-TM-ER cells that had 
been treated with 4-OHT or vehicle control. Primers fl  ank-
ing the putative Puma FHRE region were then used for 
QRT-PCR assay. We found that nuclear activated FOXO3a-
TM could bind the Puma promoter regardless of p53 geno-
type (Fig. 2 E). Collectively, our results demonstrate that 
FOXO3a can act directly on the Puma promoter in a p53-
  independent manner.
Puma is up-regulated in lymphoid cells 
upon cytokine deprivation
If exogenously expressed FOXO3a could direct Puma ex-
pression through FHRE binding, one would expect that ac-
tivation of endogenous FOXO3a should be able to regulate 
Puma. To test this, we examined Puma expression levels 
in activated T cells that were subjected to IL-2 withdrawal. 
Because Bim is a known FOXO3a downstream target under 
conditions of cytokine deprivation, we also analyzed the 
  eff  ect of IL-2 withdrawal on bim mRNA expression.
We fi  rst tested if abnormal Pten/Akt signaling had any 
eff  ect on Puma and Bim expression. Using activated T cells 
derived from Pten+/+ Lck-Cre and Ptenfl  ox/fl  ox Lck-Cre mice, 
we found the transcript levels of both bim and Puma were 
strikingly increased in Pten+/+ Lck-Cre cells in response to 
IL-2 withdrawal, whereas the loss of Pten signifi  cantly im-
paired Puma and bim induction in similarly treated Ptenfl  ox/fl  ox 
Lck-Cre T cells (Fig. 3 A). Up-regulation of these two pro-
teins upon IL-2 deprivation were also markedly impaired 
in the absence of Pten (Fig. 3 B). These results indicate that 
dysregulated Akt signaling may protect against cytokine depri-
vation-induced apoptosis partly by inhibiting the expression 
of proapoptotic BH3-only proteins such as Bim and Puma. 
Interestingly,  bim defi   ciency confers signifi  cant  protection 
against IL-2 withdrawal in activated T cells (15), whereas 
Puma defi   ciency confers relatively modest resistance, but 
nonetheless with a consistent trend, to IL-2 deprivation (Fig. 
3 C, 24 h). Most importantly, lymphocytes derived from 
bim−/− and Puma−/− compound mutant mice are signifi  cantly 
resistant to cytokine withdrawal-induced apoptosis compared 
with lymphocytes defi  cient in bim alone (Fig. 3 C, 48 h, P = 
0.017). This observation suggests a synergistic cooperation 
between these two BH3-only proteins in mediating cytokine 
deprivation-induced apoptosis and further indicates the total 
amount of activated BH3 proteins is the major determinant 
of cell death.
We next determined Puma induction in p53+/+ and 
p53−/− T cells subjected to IL-2 withdrawal. Puma mRNA 
and protein levels were markedly increased in p53+/+ and 
p53−/− T cells cultured in IL-2 free medium (Fig. 3 D, left 
and bottom). Levels of bim mRNA were also signifi  cantly 
  increased in T cells deprived of IL-2 (Fig. 3 D, right). 
Table I.  Identifi  cation of FOXO3a-inducible genes by Affy-
array (up-regulated: ↑; down-regulated: ↓)
Genes Function Validated
(QRT-PCR)
Bcl-2 binding component 
 3  (puma)
BH-3 only family member, 
apoptotic factor
+ (↑)
Cyclin-dependent kinase 
 inhibitor  1B(p27)
cell cycle regulator: G1 
checkpoint
+ (↑)
DnaJ (Hsp40) homologue, 
  subfamily C, member 12
molecular chaperones + (↑)
Insulin-like growth factor 
  I receptor, (Igf1r)
insulin signaling + (↑)
Sestrin 1 modulator of peroxide 
signaling and antioxidant 
defense
+ (↑)
Vascular endothelial 
  growth factor A (Vegfa)
vasculogenesis and 
angiogenesis
+ (↓)
Cyclin D2 cell cycle regulator: G1/S 
checkpoint
+ (↓)
Eph receptor A2 (Epha2) vasculogenesis and 
angiogenesis
+ (↓)1660  FOXO3A REGULATES PUMA EXPRESSION UPON SURVIVAL FACTOR WITHDRAWAL | You et al.
Figure 3.  FOXO3a-dependent regulation of Puma expression in 
lymphoid cells upon removing of IL-2. (A) Pten loss impairs Puma and 
bim up-regulation induced by IL-2 deprivation. RNA extracted from 
Pten+/+ Lck-Cre or Ptenfl  ox/fl  ox Lck-Cre activated T cells that were either left 
untreated or deprived of IL-2 for 10 h was subjected to QRT-PCR. Data 
represent the mean and error of four independent experiments. (B) Induc-
tion of Puma and Bim protein levels was attenuated in the absence of 
Pten. Activated T cells were deprived of IL-2 for 24 h and cell lysates 
were subjected to Western blotting with antibodies as indicated. Phos-
phorylated FOXO3a and total FOXO3a levels were determined by immuno-
precipitation and Western blotting. (C) Synergistic cooperation between 
Puma and Bim in mediating cytokine withdrawal-induced cell death in 
lymphocytes. T cells were isolated from WT, puma−/−, bim−/−, or DKO 
mice and expanded in the presence of IL-2 and mitogen. Activated T cells 
were deprived of IL-2 for the indicated times, cell viability was determined 
by PI staining, and FACS analysis. p-values (Student’s t test) were deter-
mined by comparing indicated KO T cells to WT T cells (green line) or DKO 
T cells to bim−/− T cells (red line). Data shown are means ± SD from three 
independent experiments. (D) Induction of Puma and bim mRNA (top) and 
protein levels (bottom) in activated T cells. p53+/+ and p53−/− activated 
T cells were subjected to IL-2 withdrawal for 10 h. QRT-PCR was per-
formed to detect Puma (top left) and bim (top right) expression levels. 
Fold induction was determined after normalization to TBP. Results shown 
are representative of three independent experiments conducted in dupli-
cates each time. (bottom) phosphorylated FOXO3a (Thr 32) (FOXO3a-P) 
and total FOXO3a (FOXO3a-T) were determined by immunoprecipitation 
followed by Western blotting. Puma, p53, phosphorylated Akt (Ser473) 
(Akt-P), and total Akt (Akt-T) were detected by Western blotting. 
(E) FOXO3a binds to the Puma and bim promoters. Activated T cells generated 
from p53−/− mice were cultured in IL-2–free medium for 8 h and ChIP 
assays were conducted as described in Materials and methods.JEM VOL. 203, July 10, 2006  1661
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  Collectively, these data show that, upon cytokine withdrawal in 
primary lymphoid cells, Puma is up-regulated in a manner that 
is independent of p53 but dependent on PI3K–Akt signaling.
To confi  rm that the observed induction of Bim and Puma 
was indeed mediated by activated FOXO3a, we performed 
ChIP assays using FOXO3a-specifi  c antibodies to test the 
physical interaction between endogenous FOXO3a and the 
bim or Puma promoters after IL-2 withdrawal in p53−/− lym-
phoid cells. This stimulation markedly increased the associa-
tion of FOXO3a with the Puma or bim promoters, but not 
the mdm2 promoter containing p53BE (Fig. 3 E). These data 
suggest that FOXO3a is recruited to the Puma and bim pro-
moters to regulate their transcription in response to stress 
stimuli that inactivate PI3K–Akt signaling.
FOXO3a is a direct transcriptional regulator of Puma
To investigate whether FOXO3a plays a direct role in Puma 
induction when PI3K–Akt is inactive, we ablated endoge-
nous FOXO3a expression levels using shRNA in MEFs ex-
pressing p53QSA135V. p53QSA135V is a transcriptionally inactive 
form of p53 that contains two tandem mutations, L25Q and 
W26S, in the transactivation domain as well as a secondary 
point mutation, A135V, in the DNA binding domain (16, 
17). Consistent with published data, we found that the mu-
tant cells were incapable of undergoing p53-mediated apop-
tosis in response to DNA damage (16, 17), but still maintained 
a partial response to serum starvation (unpublished data). We 
fi  rst performed RT-PCR to examine the regulation of Puma 
transcripts when p53QSA135V MEFs were starved of serum. 
Puma transcript levels were up-regulated upon serum depri-
vation in p53QSA135V MEFs, but ablation of FOXO3a abro-
gated this induction (Fig. 4 A). Because Puma−/− MEFs are 
resistant to serum starvation (9), it further suggests a critical 
role of Puma in mediating stress responses associated with ac-
tivation of FOXO transcription factors. FOXO3a-dependent 
induction of Puma in response to serum deprivation was also 
reproduced in 293T cells expressing inactive p53 (Fig. 4 B). 
These results implicate a direct role of FOXO3a in transcrip-
tionally regulating Puma.
Forkhead transcription factors are tightly regulated at 
posttranslational levels by kinases including Akt and SGK1 
(12, 18, 19). Among all the FOXO downstream targets re-
ported so far, several of them are also transcriptionally regu-
lated by p53 (13). In this report, we identifi   ed Puma as 
another common downstream target of FOXO3a and p53. 
Induction of Puma upon oncogenic signals or DNA damage 
is p53-dependent and Puma functions as an essential death 
executer in initiating mitochondrial apoptosis. Loss of Puma 
can recapitulate the majority, if not all, of the apoptotic-resis-
tant phenotype observed in p53-defi  cient primary cells (8, 9). 
Additionally, Puma can be induced in a p53-independent 
manner when cells are deprived of cytokines or growth fac-
tors. The transcription factor responsible for this induction 
has not been clearly defi  ned in the literature. Given that cy-
tokine and serum withdrawal down-regulate the PI3K–Akt 
pathway, which in turn leads to the activation of forkhead 
transcription factors, we hypothesized that FOXO3a may 
play an important role in regulating Puma and other BH3-
only proapoptotic Bcl-2 family members. Indeed, our results 
demonstrate that FOXO3a is recruited to both Puma and bim 
promoter regions and that transcription of these two genes in 
response to cytokine deprivation is regulated by FOXO3a. 
Furthermore, if a critical negative regulator of the Akt path-
way, Pten, is lost, then Akt activity remains constantly high. 
This leads to an attenuated response in Puma and bim induc-
tion upon cytokine withdrawal. This, together with other 
factors, is responsible for protecting activated T cells defi  cient 
in Pten from IL-2 withdrawal-induced apoptosis. In the con-
text of IL-2 deprivation, Bim certainly contributes more 
compared with Puma, based on results from knockout mu-
rine models. One explanation is that, in addition to being 
regulated at the transcriptional level, Bim is also regulated by 
posttranslational modifi  cation. The kinetics of the latter are 
much faster and are most likely the result of kinases (such as 
JNK) that become activated in the absence of survival cyto-
kines (20). Notably, active JNK can promote Bim activity by 
posttranslationally modifying the molecule. But in addition, 
active JNK can also promote the activation of FOXO3a 
Figure 4.  Direct role of FOXO3a in transcriptional regulating 
Puma. (A and B) FOXO3a is required for induction of Puma upon serum 
withdrawal. (left) Western blots show that FOXO3a shRNA successfully 
blocked FOXO3a expression in p53QSA135V cells (A) or 293T cells (B). Protein 
levels of Puma, Akt-T/P, and tubulin before and after serum starvation 
(24 h) were detected by Western blotting. (right) RT-PCR shows that Puma 
transcripts were elevated in serum-starved p53QSA135V cells (A) or 293T 
cells (B) expressing control shRNA (con). Ablation of endogenous FOXO3a 
by FOXO3a shRNA inhibited this elevation in Puma expression in both cell 
types. SS, serum starvation.1662  FOXO3A REGULATES PUMA EXPRESSION UPON SURVIVAL FACTOR WITHDRAWAL | You et al.
(21, 22), which in turn can transcriptionally up-regulate 
downstream target genes including Puma and bim. A reason-
able hypothesis is that transcriptional up-regulation of Puma 
and Bim by FOXO3a serves as a second wave to boost the 
intensity of the proapoptotic signal through Puma and Bim 
with subsequent activation of Bax and Bak. Unlike Bim, the 
regulation of Puma so far has only been attributed to tran-
scriptional regulation. Thus, loss of Bim has a more profound 
eff  ect on cells (because it is downstream of multiple signaling 
pathways) compared with loss of Puma in situations in which 
cytokines and growth factors are withdrawn or limiting.
Because BH3-only family members are involved in di-
verse stress responses, identifying transcription factors that 
are responsible for regulating their expression levels under dif-
ferent stress conditions is of great importance. Furthermore, be-
cause the FOXO family members share certain overlapping 
functions in response to some stimuli, it will be interesting to 
explore if other FOXOs (FOXO1 and FOXO4) could also 
regulate Puma expression upon aforementioned stimuli. 
  Because FOXOs play distinct roles during embryonic devel-
opment (23), their functional redundancy in stress response 
might be tissue-type and stress-type dependent. Interestingly, 
lymphocytes derived from FOXO3a-defi  cient mice gener-
ated by a gene trap strategy respond normally to cytokine 
withdrawal, but these mice develop a lymphoproliferative 
and infl  ammatory condition (24). Ptenfl  ox/− Lck-Cre mutant 
mice have a similar phenotype in that there is enhanced pro-
liferation of T cells and concurrent production of cytokines, 
but in addition loss of Pten renders lymphocytes resistant to 
IL-2 withdrawal, as does transgenic overexpression of consti-
tutively active Akt (25). Investigating the regulation of Bim 
or Puma expression upon germline deletion of FOXO3a 
may provide an answer.
MATERIALS AND METHODS
Mice, cell culture, and manipulation. Trp53QSA135V primary MEF cells 
were provided by G. Wahl (The Salk Institute, La Jolla, CA). To generate 
FOXO3a-related stable cell lines, MEFs were cotransfected with pECE HA-
FOXO3a (TM or DB) and a GFP plasmid in 15:1 ratio. Cells were selected 
by GFP sorting 48 h later and GFP-positive cells were pooled together for 
use in experiments. T cell–specifi  c Pten-defi  cient mice were generated as 
described previously (10). Littermates carrying Lck-Cre and the fl  oxed Pten 
mutation on both alleles (Ptenfl  ox/fl  oxLck-Cre), or Lck-Cre and the wild-type 
Pten gene (Pten+/+Lck-Cre) were used for analysis as homozygous mutant 
and wild-type mice, respectively. puma and bim double knockout mice were 
generated by breeding puma+/− bim+/− double het mice together. All mice 
were either housed in a specifi  c pathogen-free animal facility in the Ontario 
Cancer Institute (animal studies were approved by the OCI review board) or 
in accordance with the Austrian “Tierversuchsgesetz” and governed in Aus-
tria by the Bundesministerium für Bildung, Wissenschaft and Kultur; animal 
experiments were performed according to the guidelines of the Melbourne 
Directorate Animal Ethics Committee.
T cell purifi  cation, activation, and cell viability analysis. Spleen and 
lymph nodes were isolated and single cell suspensions were made. Cells were 
treated with Red Cell Lysis Buff  er and resuspended in PBS (with 10% FCS) 
containing the following biotinylated antibodies: anti–mouse B220 (RA3-
6B2), anti–mouse CD11b (m1/70), anti-Ter119 (Ly-76), and anti–mouse 
Gr1 (RB6-8C5) (BD Biosciences). After a 30-min incubation on ice, pe-
ripheral T cells were recovered by negative depletion using BD Biosciences 
IMag streptavidin particles according to manufacturer’s instructions. Cell 
culture media contained the following: Iscove media supplemented with 
10% FCS, 55 μM 2-ME, 2 mM sodium pyruvate. T cells were activated by 
adding 10 ng/ml rmIL-2, 2 ng/ml PMA, and 100 ng/ml ionomycin for 3 d, 
then expanded in IL-2 alone for a further 2 d. For lymphocytes isolated from 
puma−/−, bim−/−, or DKO, activation of T cells were performed as described 
previously (15). Cell viability was determined by propidium iodide staining 
using FACScan (Becton Dickinson).
Constructs and antibodies. The pECE-HA-FOXO3a-TM and TM∆DB 
expression plasmids were provided by M. Greenberg (Harvard Medical 
School, Boston, MA). TM is a triple mutant form of FOXO3a in which 
all three Akt phosphorylation sites are mutated to alanine (FOXO3a-TM, 
T32A/S253A/S315A) and TM∆DB is a form of TM that lacks the FOXO3a 
DNA-binding domain. In TM-ER, TM is expressed as a fusion protein with 
the modifi   ed estrogen receptor. When TM-ER binds the exogenously 
  administered inducer 4-hydro-tamoxifen (4-OHT), the TM-ER protein 
translocates to the nucleus and remains there as a constitutively active form 
of FOXO3a. ShRNA sequences: 5′-G  G  C  A  A  G  A  G  C  T  C  T  T  G  G  T  G  G  A  T  -3′ 
(murine FOXO3a); 5′-G  T  G  G  A  G  C  T  G  G  A  C  C  C  G  G  A  G  T  -3′ (human 
FOXO3a). pSIRIPP retroviral vector was used for cloning and delivering 
shRNA by either retroviral infection (MEFs) or transfection (293T cell). 
Stable cells are pools of clones selected by puromycin. Antibodies were ob-
tained from the following sources: anti-HA (12CA5, Roche); anti-phos-
pho–Akt, anti-Bim, and anti-total–Akt (Cell Signaling); anti-PTEN (clone 
6H2.1, CASCADE BioScience); and anti-Thr32-FOXO3a/anti-FOXO3a 
(Upstate Biotechnology), anti-Puma (ProSci), and anti-p53 (Santa Cruz 
Biotechnology, Inc.).
RT-PCR and real-time PCR. Total RNA was extracted with TRIzol 
(Invitrogen) and purifi  ed using the RNeasy kit (QIAGEN) according to the 
manufacturer’s protocol with the addition of “on column-DNase treatment” 
(QIAGEN). RNA (4 μg) was reverse-transcribed in a 20-μl reaction using 
the Superscript fi  rst strand RT-PCR kit (Invitrogen). After RNase H treat-
ment at 37°C for 20 min and after inactivation by incubating samples at 95°C 
for 2 min, the RT reaction was diluted. cDNA was used for RT-PCR or 
real-time PCR. Primer sequences were as follows: murine Puma: 5′-C  T  G  T-
A  T  C  C  T  G  C  A  G  C  C  T  T  T  G  C  -3′, 5′-A  C  G  G  G  C  G  A  C  T  C  T  A  A  G  T  G  C  T  -3′; 
Taqman probe: G  G  A  C  G  G  T  C  C  T  C  A  G  C  C  C  T  C  C  C  T  G  T  C  A  C  -3′; human 
Puma primer sequences were from (7); murine bim: 5′-C  G  A  C  A  G  T  C  T  C  A  G-
G  A  G  G  A  A  C  C  -3′, 5′-C  C  T  T  C  T  C  C  A  T  A  C  C  A  G  A  C  G  G  A  -3′.
ChIP assay. ChIP was performed as described previously (12). Real-time 
PCR (for quantifi  cation of ChIP assay) conditions: 94°C, 45 s; 60°C, 45 s; 
and 72°C, 45 s. Ct value of each sample was normalized to the Ct value 
obtained from PCR reaction using the corresponding input genomic DNA 
as templates. Primer sequences were as follows: murine Puma FHRE: 5′-
G  A  A  G  G  A  A  G  C  A  C  C  T  G  G  G  A  C  T  C  -3′; 5′-T  C  C  T  C  C  C  A  G  G  T  C  T  C  A  C  T-
A  G  C  -3′; murine bim FHRE 1: 5′-G  G  G  C  G  G  G  T  A  C  A  T  T  C  T  G  A  G  T  -3′; 
5′-C  A  G  G  C  T  G  C  G  A  C  A  G  G  T  A  G  T  G  -3′.
Luciferase assays. Murine Puma luciferase reporter was a gift from T. Look 
(Dana-Farber Cancer Institute, Boston, MA) (for detailed information, see 
reference 14). Mutant Puma luciferase-reporter construct was generated using 
Quickchange Site-Directed Mutagenesis Kit (Stratagene). Primer sequences 
for mutagenesis assay were 5′-G  G  C  G  G  G  T  T  T  G  T  T  T  A  C  A  G  G  G  A  A  T  G  G  G-
G  T  T  C  G  G  G  C  -3′ and 5′-G  C  C  C  G  A  A  C  C  C  C  A  T  T  C  C  C  T  G  T  A  A  A  C  A  A  A  C-
C  C  G  C  C  -3′. p53−/− MEFs were seeded in 12-well plates at a density of 
3 × 105/well and were cotransfected with FOXO3a-TM or TM∆DB (1 μg) 
and Puma promoter–driven luciferase reporter constructs (0.5 μg) together 
with 50 ng β-Galactosidase construct. At 24 h after transfection, cells were 
lysed in 100 μl lysis buff  er and luciferase activity was assayed using the 
  Luciferase Assay System kit (Promega) according to the manufacturer’s pro-
tocol. β-Galactosidase activity was assayed according to the manufacturer’s 
instructions (β-Galactosidase enzyme assay system kit; Promega). We thank JEM VOL. 203, July 10, 2006  1663
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